查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1877415

分子診斷原料酶市場：按技術、酵素類型、最終用戶、應用、組成、國家和地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Molecular Diagnostic Raw Enzyme Market, By Technology, By Enzyme Type, By End-User, By Application, By Component, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年分子診斷原料酶市場規模為 12.9856 億美元，從 2025 年到 2032 年將以 9.4% 的複合年成長率成長。

分子診斷原料酶市場涵蓋聚合酶、連接酶和逆轉錄酶等關鍵生物催化劑，這些催化劑廣泛應用於PCR、qPCR、次世代定序和其他分子檢測平台，以精確檢測遺傳物質。市場成長的主要驅動力是傳染病、腫瘤和基因篩檢等領域對先進分子診斷技術的需求不斷成長，加速了酵素的消耗。然而，高昂的生產成本和嚴格的純度要求限制了市場成長，為經濟高效的大規模生產帶來了挑戰。同時，即時診斷和快速PCR系統的新機會也為市場帶來了益處，推動了對特化和工程化酶變體的需求。利用重組酶、高保真度酶和耐熱酶來提高現代診斷工作流程的敏感度、速度和多重檢測能力，是塑造市場格局的主要趨勢。

分子診斷原料酵素市場－市場動態

癌症和傳染病發生率上升

全球癌症和傳染病發病率的不斷上升推動了對分子診斷原料酶的需求。聚合酶、連接酶和逆轉錄酶是早期檢測、監測和管理這些疾病的檢測方法中的重要組成部分。快速且準確的分子診斷能夠實現及時干預，從而改善患者預後並支持個人化醫療。據估計，到2024年，美國將新增約200萬例癌症病例，而美國疾病管制與預防中心（CDC）也報告了麻疹、登革熱和I型膿痘等重大傳染病疫情。這些日益嚴峻的醫療挑戰正在推高對分子診斷的需求，進而增加了對用於PCR、定序和其他分子檢測的高品質原料酶的需求。

分子診斷原料酵素市場細分分析：

全球市場按技術、酵素類型、最終用戶、應用、組件和地區進行細分。

分子診斷原料酵素市場主要分為腫瘤學、傳染病學、心臟病學和其他領域。其中，傳染病應用佔據了分子診斷原料酶市場相當大的佔有率，這主要得益於快速、精準病原體檢測需求的不斷成長。諸如聚合酶鍊式反應 (PCR) 和下一代定序 (NGS) 等先進的分子診斷技術高度依賴高品質的原料酶來準確識別結核病、HIV 和病毒感染等病原體。主要市場參與者正積極開發新型酵素製劑和自動化診斷解決方案，以推動該領域的成長。例如，2022 年 5 月，BD 公司在美國推出了全自動 BD COR MX 系統，該系統可在極少人工干預的情況下處理多達 1700 個樣本，並能檢測沙眼衣原體、淋病奈瑟菌和陰道毛滴蟲等病原體。這項進展強調了可靠的原始酵素在提高檢測效率、通量和準確性方面的重要性，尤其是在傳染病診斷方面。

分子診斷原料酶市場按技術類型分為酵素連結免疫吸附試驗 (ELISA)、聚合酶鍊式反應 (PCR) 和其他技術。 PCR 技術因其在實現精準、高通量分子診斷中的關鍵作用而佔據重要地位。定量 PCR、逆轉錄 PCR、反向 PCR 和多重 PCR 等 PCR 技術被廣泛用於同時檢測多個靶標，其中即時 PCR 在癌症標記分析中發揮重要作用。高通量 PCR 技術的日益普及催生了對高品質原料酶的需求，以確保精確擴增和結果的可重複性。例如，賽默飛世爾科技 (Thermo Fisher Scientific) 於 2023 年發布的 QuantStudio Absolute Q AutoRun dPCR 套件可實現實驗室工作流程自動化，從而提高效率並降低營運成本；而羅氏 (Roche) 於 2022 年發布的 Digital LightCycler 系統則提升了癌症檢測和生物標記分析能力。這些進展凸顯了 PCR 酶在腫瘤學、傳染病和基因檢測等分子診斷中的關鍵作用。

分子診斷原料酵素市場—地理分佈分析

預計到2025年，北美將成為診斷分子原料酶市場的重要收入來源地區，這主要得益於其完善的醫療保健基礎設施，為先進的診斷檢測提供了有力支持。該地區對創新體外診斷（IVD）平台的廣泛應用，也帶動了對用於各種診斷應用的原料酶的需求成長。此外，研發投入的不斷增加以及患者群體的持續擴大，進一步促進了診斷分子原料酶的使用，鞏固了該地區在維持整體市場成長方面的重要性。

加拿大分子診斷原料酶市場—國家概況

預計加拿大分子診斷原料酶市場在預測期內將顯著成長。癌症和其他慢性疾病的日益普遍，推動了對先進分子診斷解決方案的需求，以實現早期檢測和個人化治療。根據加拿大癌症協會估計，到2024年，加拿大將有247,100人被診斷出患有癌症，高於2023年的239,100例新增病例，這主要是由於該國人口老化和成長所致。此外，預計癌症相關死亡人數將從2023年的86,700人增加到2024年的88,100人，凸顯了對準確及時的診斷工具日益成長的需求。這一趨勢預計將推動分子診斷原料酶的應用，這些原料酶是PCR、定序和其他診斷檢測的關鍵組成部分，從而促進加拿大市場的成長。

分子診斷原料酵素市場－競爭格局：

分子診斷原料酵素市場競爭格局集中度適中，少數幾家關鍵企業主導創新與市場擴張。賽默飛世爾科技（Thermo Fisher Scientific）、默克集團（Merck KGaA）和新英格蘭生物實驗室（New England Biolabs）等公司專注於開發高性能酶，這些酶具有更高的穩定性、特異性和可重複性，適用於PCR、NGS和傳染病檢測等分子診斷應用。例如，默克集團於2024年發布了其DNA聚合酶的升級版，該酵素的擴增保真度提高了12%，並提升了臨床診斷實驗室的效率。對準確可靠的酵素解決方案日益成長的需求、監管合規性要求以及先進分子檢測技術的廣泛應用，都對市場競爭產生影響。各公司持續加大研發投入、拓展合作、豐富產品組合，以滿足全球醫院、研究機構和體外診斷實驗室不斷變化的診斷需求。

目錄

第1章：分子診斷原料酵素市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 分子診斷原料酵素市場技術概覽
    • 分子診斷原料酵素市場概覽（依酵素類型分類）
    • 分子診斷原料酶市場按最終用戶分類的概況
    • 分子診斷原料酶市場按應用領域分類的概覽
    • 分子診斷原料酵素市場按成分分類的概覽
    • 各國分子診斷原料酵素市場概況
    • 分子診斷原料酵素市場區域概覽
  • 競爭洞察

第3章：分子診斷原料酵素市場關鍵趨勢

  • 分子診斷原料酶市場促進因素
    • 市場促進因素的影響分析
  • 分子診斷原料酵素市場限制因素
    • 市場限制因素的影響分析
  • 分子診斷原料酵素市場機遇
  • 分子診斷原料酵素市場未來趨勢

第4章：分子診斷原料酶產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：分子診斷原料酶市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：分子診斷原料酵素市場概況

  • 2024年分子診斷原料酵素市場佔有率分析
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：分子診斷原料酶市場－依技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 酵素連結免疫吸附試驗（ELISA）
    • 聚合酶鍊式反應（PCR）
    • 其他

第8章：分子診斷原料酶市場－依酵素類型分類

  • 概述
    • 按酵素類型分類的細分市場佔有率分析
    • 聚合酶和轉錄酶
    • 核糖核酸酶
    • 蛋白酶
    • 其他

第9章：分子診斷原料酶市場－以最終用戶分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 生物技術和製藥公司
    • 醫院和診斷實驗室
    • 其他

第10章：分子診斷原料酶市場－依應用領域分類

  • 概述
    • 按酵素類型分類的細分市場佔有率分析
    • 肝功能生化診斷
    • DNA檢測
    • 傳染病診斷
    • 腫瘤診斷
    • 凝血診斷
    • 其他

第11章：分子診斷原料酵素市場－依成分分類

  • 概述
    • 按組成部分分類的細分市場佔有率分析
    • 腫瘤學
    • 傳染病
    • 心臟病學
    • 其他

第12章：分子診斷原料酶市場－依地理分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美分子診斷原料酵素主要生產商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（依技術分類）
    • 北美市場規模及預測（依酵素類型分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 北美市場規模及預測（按應用分類）
    • 北美市場規模及預測（按組件分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲分子診斷原料酵素主要生產商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（依技術分類）
    • 歐洲市場規模及預測（依酵素類型分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 歐洲市場規模及預測（按組件分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區分子診斷原料酵素主要生產商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太市場規模及預測（依技術分類）
    • 亞太地區市場規模及預測（依酵素類型分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 亞太市場規模及預測（按應用分類）
    • 亞太市場規模及預測（依組件分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲分子診斷原料酵素主要生產商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（依技術分類）
    • 拉丁美洲市場規模及預測（按酵素類型分類）
    • 拉丁美洲市場規模及預測（按最終用戶分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲規模及預測（按組成部分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲分子診斷原料酵素主要生產商
    • 中東和非洲市場規模及預測（按國家/地區分類）
    • 中東和非洲市場規模及預測（按技術分類）
    • 中東和非洲市場規模及預測（按酵素類型分類）
    • 中東和非洲市場規模及預測（按最終用戶分類）
    • 中東和非洲市場規模及預測（按應用分類）
    • 中東和非洲市場規模及預測（按組件分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第13章：分子診斷原料酵素產業主要供應商分析

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • New England Biolabs (NEB)
    • QIAGEN
    • Bio-Rad Laboratories
    • Takara Bio
    • Aldevron
    • Codexis
    • Thermo Fisher Scientific
    • Vazyme Biotech
    • Qiagen
    • Fapon Biotech
    • Yeasen Biotechnology
    • Amano Enzyme Inc.
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Enzo Life Sciences
    • MP Biomedicals
    • BBI Solutions
    • EKF Diagnostics
    • Medix Biochemica
    • Canvax Biotech
    • Others

第14章：360度分析師視角

第15章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5758

The Molecular Diagnostic Raw Enzyme Market size was valued at US$ 1,298.56 Million in 2024, expanding at a CAGR of 9.4% from 2025 to 2032.

The Molecular Diagnostic Raw Enzyme Market includes essential biological catalysts like polymerases, ligases, and reverse transcriptases, which are used in PCR, qPCR, next-generation sequencing, and other molecular testing platforms to detect genetic material accurately. The market is being driven by increased demand for advanced molecular diagnostics in infectious disease, oncology, and genetic screening applications, which is accelerating enzyme consumption. However, high manufacturing costs and stringent purity requirements limit growth, posing challenges for cost-effective large-scale production. At the same time, the market benefits from new opportunities in point-of-care diagnostics and rapid PCR systems, which drive demand for specialized and engineered enzyme variants. The use of recombinant, high-fidelity, and thermostable enzymes to improve sensitivity, speed, and multiplexing capabilities in modern diagnostic workflows is a major trend shaping the landscape.

Molecular Diagnostic Raw Enzyme Market- Market Dynamics

Rising Prevalence of Cancer and Infectious Diseases

The rising prevalence of cancer and infectious diseases worldwide is driving demand for molecular diagnostic raw enzymes. Polymerases, ligases, and reverse transcriptases are important components in assays for early detection, monitoring, and management of these conditions. Rapid and accurate molecular diagnostics allow for timely interventions, which improves patient outcomes and supports personalized medicine approaches. According to estimates for 2024, approximately 2 million new cancer cases will be diagnosed in the United States, while the CDC has reported significant infectious disease outbreaks such as measles, dengue fever, and a Clade I mpox case. These growing healthcare challenges are driving up demand for molecular diagnostics, which in turn increases the demand for high-quality raw enzymes for PCR, sequencing, and other molecular assays.

Molecular Diagnostic Raw Enzyme Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Technology, Enzyme Type, End-User, Application, Component, and Region.

The Molecular Diagnostic Raw Enzyme market component is primarily categorized into Oncology, Infectious Diseases, Cardiology, and Others. Among which. The infectious disease application accounts for a significant portion of the Molecular Diagnostic Raw Enzyme Market, driven by rising demand for rapid and precise pathogen detection. Advanced molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), rely heavily on high-quality raw enzymes to accurately identify pathogens like tuberculosis, HIV, and viral infections. Key market players are actively supporting the expansion of this segment by developing novel enzyme formulations and automated diagnostic solutions. For instance, in May 2022, BD introduced the fully automated BD COR MX system in the United States, which can process up to 1,700 specimens with minimal staff interaction while detecting pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. This advancement emphasizes the importance of dependable raw enzymes in improving testing efficiency, throughput, and accuracy, especially in infectious disease diagnostics.

Molecular Diagnostic Raw Enzyme Market Technology type is divided into Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), and Others, The PCR segment is an important one due to its critical role in enabling accurate and high-throughput molecular diagnostics. PCR technologies, such as quantitative PCR, reverse transcription PCR, inverse PCR, and multiplex PCR, are widely used to detect multiple targets at once, with real-time PCR playing an important role in cancer marker analysis. The growing use of high-throughput PCR techniques has created a demand for high-quality raw enzymes to ensure precise amplification and reproducible results. For example, Thermo Fisher Scientific's QuantStudio Absolute Q AutoRun dPCR Suite, released in 2023, automates laboratory workflows, increasing efficiency and lowering operational costs, whereas Roche's Digital LightCycler System, released in 2022, improved cancer detection and biomarker analysis capabilities. These advancements highlight the critical role of PCR enzymes in molecular diagnostics across oncology, infectious diseases, and genetic testing.

Molecular Diagnostic Raw Enzyme Market- Geographical Insights

North America represents a significant revenue-generating region in the Diagnostic Molecule Raw Enzymes Market in 2025, driven by a well-established healthcare infrastructure that supports advanced diagnostic testing. The region's adoption of innovative in-vitro diagnostic (IVD) platforms has increased the demand for raw enzymes used in various diagnostic applications. Additionally, rising investments in R&D, coupled with a growing patient population, have further contributed to the utilization of diagnostic molecule raw enzymes, reinforcing the region's importance in sustaining overall market growth.

Canada Molecular Diagnostic Raw Enzyme Market- Country Insights

The Canada Molecular Diagnostic Raw Enzyme Market is expected to grow significantly over the forecast period. The rising prevalence of cancer and other chronic diseases is increasing demand for advanced molecular diagnostic solutions that allow for early detection and personalized treatment. According to the Canadian Cancer Society, an estimated 247,100 Canadians will be diagnosed with cancer in 2024, up from 239,100 new cases in 2023, owing primarily to the country's aging and growing population. Furthermore, cancer-related deaths are expected to rise from 86,700 in 2023 to 88,100 in 2024, highlighting the growing need for accurate and timely diagnostic tools. This trend is expected to drive the adoption of molecular diagnostic raw enzymes, which are critical components in PCR, sequencing, and other diagnostic assays, boosting market growth in Canada.

Molecular Diagnostic Raw Enzyme Market- Competitive Landscape:

The Molecular Diagnostic Raw Enzyme Market has a moderately concentrated competitive landscape, with a few key players driving innovation and market expansion. Thermo Fisher Scientific, Merck KGaA, and New England Biolabs are among the key companies that specialize in the development of high-performance enzymes with improved stability, specificity, and reproducibility for molecular diagnostics applications such as PCR, NGS, and infectious disease testing. Merck KGaA, for example, released an upgraded version of its DNA polymerase enzyme in 2024, which improved amplification fidelity by 12% and increased efficiency in clinical diagnostic laboratories. The growing demand for accurate and reliable enzyme solutions, regulatory compliance, and the increasing adoption of advanced molecular testing technologies all influence market competition. Companies continue to invest in R&D, partnerships, and portfolio diversification to meet changing diagnostic needs in hospitals, research institutions, and IVD laboratories worldwide.

Recent Developments:

In June 2025, Enzo Biochem, Inc. announced that it had signed a definitive Agreement and Plan of Merger with Battery Ventures, a global technology investment firm. Battery, through its newly formed entity Bethpage Parent, Inc., will acquire Enzo for $0.70 per share in cash, for a total transaction value of approximately $37 million. This acquisition could have an impact on the distribution and availability of Enzo's enzyme assay kits, including those for alkaline phosphatase, lactate dehydrogenase, and glucose oxidase, as well as the company's overall diagnostics portfolio.

In September 2024, Promega unveiled a newly engineered polymerase intended to significantly reduce stuttering in forensic DNA analysis. By reducing stutter artifacts, the enzyme greatly simplifies the interpretation of mixed DNA samples, allowing forensic scientists to generate more accurate profiles from multiple sources. This breakthrough is the first enzyme designed specifically to address one of the most persistent challenges in DNA forensics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • New England Biolabs (NEB)
  • QIAGEN
  • Bio-Rad Laboratories
  • Takara Bio
  • Aldevron
  • Codexis
  • Thermo Fisher Scientific
  • Vazyme Biotech
  • Qiagen
  • Fapon Biotech
  • Yeasen Biotechnology
  • Amano Enzyme Inc.
  • Advanced Enzymes Technologies Ltd.
  • Biocatalysts Ltd.
  • Enzo Life Sciences
  • MP Biomedicals
  • BBI Solutions
  • EKF Diagnostics
  • Medix Biochemica
  • Canvax Biotech
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY ENZYME TYPE - MARKET ANALYSIS, 2019 - 2032

  • Polymerase & Transcriptase
  • Ribonuclease
  • Proteases
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Biotech & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Liver Function Biochemical Diagnosis
  • DNA Testing
  • Infectious Disease Diagnosis
  • Tumor Diagnosis
  • Coagulation Diagnosis
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Diagnostic Raw Enzyme Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Diagnostic Raw Enzyme Market Snippet by Technology
    • 2.1.2. Molecular Diagnostic Raw Enzyme Market Snippet by Enzyme Type
    • 2.1.3. Molecular Diagnostic Raw Enzyme Market Snippet by End-User
    • 2.1.4. Molecular Diagnostic Raw Enzyme Market Snippet by Application
    • 2.1.5. Molecular Diagnostic Raw Enzyme Market Snippet by Component
    • 2.1.6. Molecular Diagnostic Raw Enzyme Market Snippet by Country
    • 2.1.7. Molecular Diagnostic Raw Enzyme Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Diagnostic Raw Enzyme Key Market Trends

  • 3.1. Molecular Diagnostic Raw Enzyme Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Diagnostic Raw Enzyme Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Diagnostic Raw Enzyme Market Opportunities
  • 3.4. Molecular Diagnostic Raw Enzyme Market Future Trends

4. Molecular Diagnostic Raw Enzyme Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Diagnostic Raw Enzyme Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Diagnostic Raw Enzyme Market Landscape

  • 6.1. Molecular Diagnostic Raw Enzyme Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Diagnostic Raw Enzyme Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Others

8. Molecular Diagnostic Raw Enzyme Market - By Enzyme Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Enzyme Type, 2024 & 2032 (%)
    • 8.1.2. Polymerase & Transcriptase
    • 8.1.3. Ribonuclease
    • 8.1.4. Proteases
    • 8.1.5. Others

9. Molecular Diagnostic Raw Enzyme Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Biotech & Pharmaceutical Companies
    • 9.1.3. Hospitals & Diagnostic Laboratories
    • 9.1.4. Others

10. Molecular Diagnostic Raw Enzyme Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Enzyme Type, 2024 & 2032 (%)
    • 10.1.2. Liver Function Biochemical Diagnosis
    • 10.1.3. DNA Testing
    • 10.1.4. Infectious Disease Diagnosis
    • 10.1.5. Tumor Diagnosis
    • 10.1.6. Coagulation Diagnosis
    • 10.1.7. Others

11. Molecular Diagnostic Raw Enzyme Market - By Component

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 11.1.2. Oncology
    • 11.1.3. Infectious Diseases
    • 11.1.4. Cardiology
    • 11.1.5. Others

12. Molecular Diagnostic Raw Enzyme Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Molecular Diagnostic Raw Enzyme Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. New England Biolabs (NEB)
    • 13.2.2. QIAGEN
    • 13.2.3. Bio-Rad Laboratories
    • 13.2.4. Takara Bio
    • 13.2.5. Aldevron
    • 13.2.6. Codexis
    • 13.2.7. Thermo Fisher Scientific
    • 13.2.8. Vazyme Biotech
    • 13.2.9. Qiagen
    • 13.2.10. Fapon Biotech
    • 13.2.11. Yeasen Biotechnology
    • 13.2.12. Amano Enzyme Inc.
    • 13.2.13. Advanced Enzymes Technologies Ltd.
    • 13.2.14. Biocatalysts Ltd.
    • 13.2.15. Enzo Life Sciences
    • 13.2.16. MP Biomedicals
    • 13.2.17. BBI Solutions
    • 13.2.18. EKF Diagnostics
    • 13.2.19. Medix Biochemica
    • 13.2.20. Canvax Biotech
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us